Identifying COPD in lung cancer screening patients
Official title: Temple Health Chest Initiative (THCI 2.0) - Lung Cancer Screening Project With COPD Detection
Run by Temple University · NCT06933758 · Data updated 2026-11-12
This study is trying to find out how many people aged 50 to 80 who are getting lung cancer screenings actually have undiagnosed COPD and how early diagnosis might help them.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 50 Years to 80 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Temple University Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Status | Recruiting |
| Started | February 28, 2025 |
| Main results expected | May 31, 2026 |
| Study ends | June 30, 2026 |
| Registry record updated | April 18, 2025 |
| Trial ID | NCT06933758 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 50 to 80 who are undergoing lung cancer screening with low-dose CT imaging.
✕Probably not a fit
Patients under 50 or over 80 years old, or those not screened for lung cancer, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to determine the prevalence of chronic obstructive pulmonary disease (COPD) among patients aged 50 to 80 who are being screened for lung cancer using low-dose CT imaging. By utilizing spirometry, CT scans, and symptom assessments, the study seeks to identify undiagnosed COPD cases and understand the impact of early diagnosis on patient outcomes. The research will also explore imaging biomarkers related to COPD and their potential role in assessing disease progression over time.
Why it matters
Potential benefit: If successful, this study could lead to earlier diagnosis and better management of COPD in high-risk patients, potentially improving their quality of life and health outcomes.
How similar studies have gone: Other studies have shown success in identifying COPD through lung cancer screening programs, indicating a promising approach for this population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 50 to 80 years old * Screened for early lung cancer using low dose CT imaging Exclusion Criteria: * Under 50; over 80 years old * No lung cancer screening
Where it's running
-
Temple University Of the Commonwealth System of Higher Education
Philadelphia, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Gerard Criner, MD — Temple University
- Study coordinator: Lauren Miller, BS
- Email: lauren.e.miller@temple.edu
- Phone: 215-707-4821
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Chronic Respiratory Disease Participant Engagement
This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.
-
IOS-based platform to screen, diagnose, and manage COPD and asthma
This study tests an Impulse Oscillometry system to screen for and diagnose COPD and asthma and to help predict flare-ups over about a year, involving adults in China.
-
Targeted NMES to improve breathing and leg/extra muscle strength in COPD
This study tests whether targeted neuromuscular electrical stimulation helps people with COPD see improvements in breathing muscle function and overall muscle strength.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
-
PBMT with a pulmonary rehab program for COPD patients
A small randomized trial tests whether adding photobiomodulation therapy before exercise in a COPD pulmonary rehab program helps improve functional capacity.
-
Controlled versus standard oxygen therapy for ICU COPD with acute exacerbation
This trial tests whether keeping oxygen levels at 88-92% helps ICU patients with an acute COPD flare more than keeping levels above 94%.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.